Manchester Financial Inc Gsk PLC Transaction History

Manchester Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$36.52 - $41.46 $25,381 - $28,814	-695 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$34.27 - $40.01 $1,884 - $2,200	-55 Reduced 7.33%	695 $25,000
Q4 2020 Jan 26, 2021	SELL	$34.07 - $39.94 $2,384 - $2,795	-70 Reduced 8.54%	750 $28,000
Q2 2020 Jul 13, 2020	BUY	$37.87 - $43.58 $24,615 - $28,327	650 Added 382.35%	820 $33,000
Q1 2020 Apr 20, 2020	SELL	$32.47 - $48.83 $25,976 - $39,064	-800 Reduced 82.47%	170 $6,000
Q4 2019 Jan 17, 2020	BUY	$42.0 - $48.25 $40,740 - $46,802	970 New	970 $46,000
Q3 2019 Oct 09, 2019	SELL	$40.46 - $43.52 $39,246 - $42,214	-970 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$39.4 - $42.7 $38,218 - $41,419	970 New	970 $39,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.